ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,895,000 | -58.3% | 2,827,000 | +17.6% | 0.18% | -64.7% |
| Q1 2021 | $23,708,000 | -9.0% | 2,404,439 | 0.0% | 0.50% | -3.3% |
| Q4 2020 | $26,064,000 | +5.2% | 2,404,439 | 0.0% | 0.52% | -14.6% |
| Q3 2020 | $24,766,000 | +42.2% | 2,404,439 | +188.3% | 0.60% | +18.9% |
| Q2 2020 | $17,412,000 | -14.1% | 833,895 | -59.8% | 0.51% | -21.2% |
| Q1 2020 | $20,273,000 | +732.6% | 2,075,000 | +881.8% | 0.64% | +724.4% |
| Q4 2019 | $2,435,000 | -0.5% | 211,343 | -49.9% | 0.08% | -8.2% |
| Q1 2018 | $2,448,000 | – | 422,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |